A promising new therapy to stop Parkinson’s disease in its tracks has been developed at The University of Queensland. UQ Faculty of Medicine researcher Associate Professor Trent Woodruff said the team found that a small molecule, MCC950, stopped the development of Parkinson’s in several animal models. The NLRP3 inflammasome (green) is expressed by immune cells...
Category: <span>Proteomics</span>
Post
Muscle-building proteins hold clues to ALS, muscle degeneration
Toxic protein assemblies, or “amyloids,” long considered to be key drivers in many neuromuscular diseases, also play a beneficial role in the development of healthy muscle tissue, University of Colorado Boulder researchers have found. Physician-scientists and competitive runners Josh Wheeler left, and Thomas Vogler on the summit of Long’s Peak in Colorado. Credit: CU Boulder...